Novabridge Biosciences share price logo

Novabridge Biosciences Share Price

NASDAQ: NBP

Small Cap

$2.53

-0.10

(-3.80%)

as on

Novabridge Biosciences Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.44
    $2.61
    downward going graph

    3.56%

    Downside

    3.16%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Novabridge Biosciences share price movements today

Previous Close
$2.63
Open
$2.61
Volume
1.5M
Day's Low - High
$2.44 - $2.61

Novabridge Biosciences Historical Returns

1 Month Return
-19.82 %
3 Month Return
-43.2 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Novabridge Biosciences Stock Fundamentals & Key Indicators

Check Novabridge Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$295.1M

EPS (TTM)

-0.185

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Novabridge Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novabridge Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Novabridge Biosciences image
Novabridge Biosciences
NA$295.1MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Novabridge Biosciences Stock’s Investor Sentiment and Interest

Search interest for Novabridge Biosciences Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-33% versus previous 30 day period

Novabridge Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
9
9
3
1
-
-
-
-
-
-
Gross Profit
9
9
3
-19
-
-
-
-
-
-1
Operating Income
-335
-335
-282
-90
-15
-12
-12
-5
-7
-64
EBITDA
-50
323
-275
-84
-103
-6
-
-5
-7
-62
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
0
0
-
-
0
Income Before Tax
-386
-386
-346
-69
-49
-20
-10
-3
-5
-48
Income Tax Expense
0
-
-
-
-42
-
-
-
-
-
Net Income
-386
-386
-346
20
25
-20
-9
-3
-5
-48
Net Profit Margin
-3931.80%
-3931.80%
-8673.15%
1835.25%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Novabridge Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
11
53
30
1,542
13
-1
0
-
Gross Profit
11
53
30
1,542
6
-35
0
-
Operating Income
-280
-438
-1,464
155
-2,071
-366
-511
-375
EBITDA
-279
-431
-197
168
-2,057
-51
-344
-373
Interest Expense
0
1
0
0
-
0
0
-
Depreciation
-
-
-
-
5
1
1
0
Income Before Tax
-298
-401
-1,451
483
-2,332
-973
-1,465
-362
Income Tax Expense
-
1
-
12
0
0
-1,258
-
Net Income
-298
-402
-1,485
470
-366
-359
-205
-162
Net Profit Margin
-2580.82%
-749.02%
-4950.00%
30.53%
-2648.70%
23438.90%
-32674.02%
0.00%

Novabridge Biosciences Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-386
-346
20
180
-143
-9
-22
-13
-48
Operating Cash Flow
-
-
-
-
8
-10
-
-
13
Investing Cash Flow
-
-
-
-
-
-
-
-
0
Financing Cash Flow
-
-
-
-
-
-
-
-
433
Change in Cash
-225
-
-
-
-72
-11
-
-
446

Novabridge Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-402
-1,451
470
-2,331
-2,507
-208
-49
Operating Cash Flow
-280
-867
433
-973
-1,102
-72
-52
Investing Cash Flow
9
212
-201
-727
458
-107
-135
Financing Cash Flow
1,479
152
3,440
593
42
-8
0
Change in Cash
1,268
-487
3,565
-1,235
-212
-151
-233

Insights on Novabridge Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NBP has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Novabridge Biosciences has experienced a drawdown of -15.2%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 5.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, NBP stock has moved down by -43.2%

About Novabridge Biosciences

Novabridge Biosciences is a global biotechnology platform company. The Company combines deep business development expertise with agile translational clinical development to identify, accelerate, and advance breakthrough assets. Its differentiated pipeline includes givastomig, a bispecific antibody (Claudin 18.2 x 4-1BB), and VIS-101, a bifunctional biologic, targeting VEGF-A and ANG2. Givastomig conditionally activates T cells via the 4-1BB signaling pathway in the tumor microenvironment where Claudin 18.2 is expressed. Givastomig is being developed to treat Claudin 18.2-positive gastric cancer and other gastrointestinal malignancies. VIS-101 targets VEGF-A and ANG-2 to provide more potent and durable treatment benefits for patients with wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). VIS-101 is completing a large, randomized, dose-ranging Phase 2 study for wet AMD.
OrganisationNovabridge Biosciences
Headquarters2440 Research Boulevard, Rockville, MD, United States, 20850
CEODr. Xi-Yong Fu M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Novabridge Biosciences

Name

Title

Dr. Phillip Dennis M.D., Ph.D.

Chief Medical Officer

Mr. Sean Wuxiong Cao M.B.A., Ph.D.

Chief Business Development Officer & Independent Director

Mr. Wei Fu

Executive Chairman

Dr. Xi-Yong Fu M.B.A., Ph.D.

CEO & Director

Kyler Lei

Chief Financial Officer

Mr. Tyler Ehler

Senior Director of Investor Relations

Dr. Claire Xu M.D., Ph.D.

Senior Vice President of Clinical Development

FAQs

What is Novabridge Biosciences share price today?

Novabridge Biosciences share price today is $2.53 as on at the close of the market. Novabridge Biosciences share today touched a day high of $2.61 and a low of $2.44.

What is the 52 week high and 52 week low for Novabridge Biosciences share?

Novabridge Biosciences share touched a 52 week high of $ on and a 52 week low of $ on . Novabridge Biosciences stock price today i.e. is closed at $2.53,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Novabridge Biosciences's market capitalisation today?

Novabridge Biosciences market capitalisation is $0.00T as on .

How to invest in Novabridge Biosciences Stock (NBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Novabridge Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novabridge Biosciences Shares that will get you 0.5929 shares as per Novabridge Biosciences share price of $2.53 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Novabridge Biosciences Stock (NBP) from India?

Indian investors can start investing in Novabridge Biosciences (NBP) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Novabridge Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Novabridge Biosciences share’s latest price of $2.53 as on March 25, 2026 at 1:29 am IST, you will get 3.9526 shares of Novabridge Biosciences. Learn more about fractional shares .